Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06505746
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-11
Brief Title:
A Study of Real-world Treatment of Adults With Urothelial Cancer in South Korea and Saudi Arabia
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Adelphi Real World Metastatic Urothelial Cancer Disease Specific Programme Study of Real-world Data to Evaluate Patient Characteristics Treatment Pattern and Healthcare Resource Utilisation of Locally Advanced or Metastatic Urothelial Cancer LamUC at First-line Setting Post Avelumab Reimbursement in South Korea and Saudi Arabia
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Cancer in the bladder lining urothelial cancer can be treated in many ways One way is to directly attack cancer cells Enfortumab vedotin is a treatment that can do this Another way is to help the bodys immune system find and attack cancer cells Avelumab is a treatment that can do this Both treatments were recently approved in some countries
Doctors have standard clinical practice guidelines to help them treat people with cancer This study is about collecting information on how adults with urothelial cancer are treated in standard clinical practice The people in this study will have locally advanced or metastatic urothelial cancer Locally advanced means the cancer has spread to tissue close by
Metastatic means the cancer has spread to other parts of the body
The goal of this study is to learn how people with urothelial cancer receive medical care in clinics in South Korea and Saudi Arabia The main goals are to learn more about the people receiving treatments and the treatments they receive
This study is about collecting information only The individuals doctor decides on treatment not the study sponsor Astellas
Information will be collected from the peoples medical records This will include 12 months before treatment starts and during treatment Also doctors will answer questions in interviews and surveys about how they care for people with urothelial cancer
Doctors have standard clinical practice guidelines to help them treat people with cancer This study is about collecting information on how adults with urothelial cancer are treated in standard clinical practice The people in this study will have locally advanced or metastatic urothelial cancer Locally advanced means the cancer has spread to tissue close by
Metastatic means the cancer has spread to other parts of the body
The goal of this study is to learn how people with urothelial cancer receive medical care in clinics in South Korea and Saudi Arabia The main goals are to learn more about the people receiving treatments and the treatments they receive
This study is about collecting information only The individuals doctor decides on treatment not the study sponsor Astellas
Information will be collected from the peoples medical records This will include 12 months before treatment starts and during treatment Also doctors will answer questions in interviews and surveys about how they care for people with urothelial cancer
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None